The Fundamentals and Role of Antipsychotic TDM in Clinical Decision Making
First presented in October 2024 at the European Society of Clinical Pharmacy in Krakow, Poland
Description:
Therapeutic Drug Monitoring (TDM) of oral and long-acting injectable (LAI) antipsychotic medications plays a critical role in optimizing patient care. Dr. Schoretsanitis provides expert insights into key considerations when using antipsychotic medications, including the clinical decision-making process for transitioning to LAIs and monitoring strategies. In addition, this session explores how TDM supports personalized treatment strategies, improves clinical decision-making, and enhances patient outcomes.
Presenting Faculty:
Georgios Schoretsanitis, MD, PhD
- Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of
Psychiatry, University of Zurich; Zurich, Switzerland - Department of Psychiatry, The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks; New York, NY
- Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell; Hempstead, NY
Additional Resources:
For additional handouts, questions, or inquiries, please contact hello@saladax.com or enter your email below!
